{{Rsnum
|rsid=10259085
|Gene=C1GALT1
|Chromosome=7
|position=7228800
|Orientation=plus
|GMAF=0.4017
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=C1GALT1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 19.8 | 59.5 | 20.7
| HCB | 11.0 | 39.7 | 49.3
| JPT | 6.2 | 44.6 | 49.1
| YRI | 1.4 | 26.5 | 72.1
| ASW | 3.5 | 38.6 | 57.9
| CHB | 11.0 | 39.7 | 49.3
| CHD | 11.0 | 32.1 | 56.9
| GIH | 44.6 | 44.6 | 10.9
| LWK | 3.6 | 31.8 | 64.5
| MEX | 35.1 | 43.9 | 21.1
| MKK | 8.3 | 35.3 | 56.4
| TSI | 33.3 | 39.2 | 27.5
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19010793
|Trait=Multiple sclerosis (severity)
|Title=Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis
|RiskAllele=
|Pval=0.000004
|OR=NR
|ORtxt=NR
}}

{{PharmGKB
|RSID=rs10259085
|Name_s=
|Gene_s=C1GALT1
|Feature=
|Evidence=PubMed ID:19010793; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. (Initial Sample Size: 794 cases, 883 controls; Replication Sample Size: NR); (Region: 7p21.3; Reported Gene(s): C1GALT1; Risk Allele: rs10259085-?); (p-value= 0.000004).This variant is associated with Multiple sclerosis (severity).
|Drugs=
|Drug Classes=
|Diseases=Multiple Sclerosis
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740730
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs10259085
|overall_frequency_n=85
|overall_frequency_d=128
|overall_frequency=0.664062
|n_genomes=49
|n_genomes_annotated=0
|n_haplomes=75
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}